(AVDL) – PRNewswire
-
Illuminate Hypersomnia Initiative Shines Light on What It's Like to Live with Idiopathic Hypersomnia
-
Heron Therapeutics Enters into Cooperation Agreement with Rubric Capital and Velan Capital
-
PM360 Magazine Announces Winners of 2022 Trailblazer Awards
-
PM360 Announces 2022 Trailblazer Award Finalists
-
NRx Pharmaceuticals Announces the Appointment of Stephen Willard, Chief Executive Officer and Director
-
NATIONAL SLEEP FOUNDATION'S 2022 SLEEP IN AMERICA® POLL: Americans Can Do More During the Day and Night to Improve Sleep
-
Paragon Biosciences Appoints Jordan Dubow as Chief Medical Officer
-
The Subcutaneous Biologic Drugs and Affiliated Technologies Market is Estimated to be Worth Over USD 180 Billion by 2030, Claims Roots Analysis
-
LongueVue Capital Adds Experienced Healthcare Operating Partners to Support New & Existing Investments
Back to AVDL Stock Lookup